Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

doi:10.3748/wjg.v9.i4.688

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2879)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

328

HTML

2358

Figures (1-5)

193

Sum=2879

Apr 15, 2003 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 15, 2003; 9(4): 688-691
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.688

Full Size Figure Download Figure

Figure 5 The expression of EGFP suppressed by ATRA. A. stable expression of EGFP in HepG2; B. expression of EGFP suppressed by 2.5 × 10^-7 M ATRA.

Citation: Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Wang WY. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma. World J Gastroenterol 2003; 9(4): 688-691
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/688.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i4.688